It was a pleasure to catch up with Dr David Hunter (Harvard Medical School, Boston, MA, USA) about the dichoptic digital therapeutic for amblyopia.
Questions
- What are the greatest challenges of amblyopia therapy, in children? (00:17)
- Could you give us a brief overview of the dichoptic digital approaches that are being investigated in amblyopia? (01:17)
- Could you tell us a little more about Luminopia One? (02:59)
Speaker Disclosure: David Hunter discloses the following: Advisor and equity holder, Luminopia, Inc. Board member and equity holder, Rebion Inc.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of AAPOS 2021.
